Vectors in Gene Therapy

The delivery of genes into DNA for gene therapy is done through the use of vectors, which are often viral vectors. These vectors can be manipulated to include DNA and RNA depending on the type of therapy that is needed. Here is the latest research on vector gene therapy.

September 12, 2020
Open Access

Development of Theranostic Cationic Liposomes Designed for Image-Guided Delivery of Nucleic Acid

Hai Doan DoNathalie Mignet
September 13, 2020
Open Access

Sonodelivery in Skeletal Muscle: Current Approaches and Future Potential

Richard E DeckerMarxa L Figueiredo
September 12, 2020

Inducing Tumor Cell Apoptosis: Mediated Survivin miRNA by Ultrasound and Cationic Lipid Contrast Agent

Current Molecular Medicine
Feng YangZhi-Yi Chen
September 3, 2020

Bundling of mRNA strands inside polyion complexes improves mRNA delivery efficiency in vitro and in vivo

Kyoko KojiSatoshi Uchida
September 12, 2020

Direct convective delivery of adeno-associated virus gene therapy for treatment of neurological disorders

Journal of Neurosurgery
Russell R LonserKrystof S Bankiewicz
September 17, 2020

Rapid determination of full and empty adeno-associated virus capsid ratio by capillary isoelectric focusing

Current Molecular Medicine
Tingting LiAndras Guttman
September 11, 2020

Restoring the natural tropism of AAV2 vectors for human liver

Science Translational Medicine
Marti Cabanes-CreusLeszek Lisowski
September 9, 2020

Innovative Therapies for Hemoglobin Disorders

BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
Karine Sii-FeliceEmmanuel Payen
September 17, 2020

Semantic verbal fluency task: The effects of age, educational level, and sex in Lebanese-speaking adults

Applied Neuropsychology. Adult
Fatima JebahiCharles Ellis
August 29, 2020
Open Access

AAV Gene Transfer to the Heart

Methods in Molecular Biology
Suya WangWilliam T Pu
September 17, 2020
Open Access

Trinucleotide Repeat-Targeting dCas9 as a Therapeutic Strategy for Fuchs' Endothelial Corneal Dystrophy

Translational Vision Science & Technology
Ziye RongV Vinod Mootha
September 3, 2020
Open Access

Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus

Journal of Cardiovascular Translational Research
Piotr BarćJan Paweł Skóra
September 15, 2020
Open Access

Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications

International Journal of Nanomedicine
Elsa Patricia RondonJulio Cesar Fernandes
September 5, 2020

Phosphorus dendrimers as powerful nanoplatforms for drug delivery, as fluorescent probes and for liposome interaction studies: A concise overview

European Journal of Medicinal Chemistry
Dzmitry ShcharbinJean-Pierre Majoral

Sign up to follow this feed and discover related papers.

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

© 2020 Meta ULC. All rights reserved